 Home > Biochemistry News > Biotechnology News > Only half a month after the clinical trial application was approved, the first subject was administered in the US Phase I clinical trial of ASC43F

Only half a month after the clinical trial application was approved, the first subject was administered in the US Phase I clinical trial of ASC43F

 Last Update: 2022-02-26
 Source: Internet
 Author: User

Tags

strength development

phentermine fda approved

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

SHANGHAI, Nov.

ASC43F is a fixed-dose single-tablet combination of 5 mg ASC41 (a thyroid hormone beta agonist) and 15 mg ASC42 (a farnesoid X receptor agonist) administered once daily

Phase I clinical trial data showed that ASC42 was safe and well tolerated, no pruritus symptoms were observed during the 14-day treatment period of 15 mg once daily, and low-density lipoprotein cholesterol levels were maintained during the treatment period

Animal studies showed that the pharmacokinetic parameters of ASC42 and ASC41A (active metabolites of ASC41) derived from ASC43F tablets were consistent with those of ASC42 and ASC41 single tablets

Dr.

Melissa Palmer, MD, Chief Medical Officer of Ganlai, said: "I am proud of the excellent execution of our clinical development team as we received FDA approval for this clinical trial nearly two weeks ago

About Song Li

Ascletis is an innovative R&D-driven biotechnology company listed on the Hong Kong Stock Exchange (1672.

Viral diseases: (1) Hepatitis B (functional cure): Explore a treatment plan based on subcutaneous injection of PD-L1 antibody ASC22 and Pegasys® as cornerstone drugs, combined with other target drugs, which is expected to bring about functional cure of hepatitis B.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.